Bain-backed Cardurion raises $260M to fund ex-Imara drug, buy more cardio assets

Car­du­ri­on Phar­ma­ceu­ti­cals is go­ing shop­ping for more car­dio drug can­di­dates.

The Burling­ton, MA-based biotech, which launched in 2017 with a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.